# U.S. GoldMining Inc.: financial statements, quarterly

USGO · Nasdaq · CIK 1947244 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/usgo.md) · [Financials](/companies/usgo/financials.md) · [Filings](/companies/usgo/filings.md) · [Insiders](/companies/usgo/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/usgo/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2023-09-30) | Q4 FY2023 (2023-11-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $k | [(3,347)](/filings/0001493152-24-045164.md) | [(3,887) d](/filings/0001641172-25-000962.md) | [(1,107)](/filings/0001641172-25-010324.md) | [(1,611)](/filings/0001641172-25-023554.md) | [(4,429)](/filings/0001493152-25-022369.md) | [(1,746) d](/filings/0001493152-26-011885.md) | [(1,319)](/filings/0001493152-26-022787.md) | [(927)](/filings/0001493152-26-037397.md) | [(2,836)](/filings/0001493152-25-022369.md) | [(2,036) d](/filings/0001493152-26-011885.md) | [(1,984)](/filings/0001493152-26-022787.md) | [(4,232)](/filings/0001493152-26-037397.md) |
| Income tax | $k | not reported | not reported | not reported | [2.9](/filings/0001641172-25-023554.md) | [1.2](/filings/0001493152-25-022369.md) | [0.8 d](/filings/0001493152-26-011885.md) | [3.3](/filings/0001493152-26-022787.md) | [0.1](/filings/0001493152-26-037397.md) | [0.0 d](/filings/0001493152-25-022369.md) | [0.7 d](/filings/0001493152-26-011885.md) | not reported | not reported |
| Net income | $k | [(3,161)](/filings/0001493152-24-045164.md) | [(3,734) d](/filings/0001641172-25-000962.md) | [(962)](/filings/0001493152-25-022369.md) | [(1,487)](/filings/0001493152-25-022369.md) | [(4,346)](/filings/0001493152-25-022369.md) | [(1,692) d](/filings/0001493152-26-011885.md) | [(1,292)](/filings/0001493152-26-037397.md) | [(905)](/filings/0001493152-26-037397.md) | [(2,815)](/filings/0001493152-25-022369.md) | [(1,980) d](/filings/0001493152-26-011885.md) | [(1,930)](/filings/0001493152-26-037397.md) | [(4,206)](/filings/0001493152-26-037397.md) |
| Diluted EPS | $ per share | [(0.25)](/filings/0001493152-24-045164.md) | not reported | [(0.08)](/filings/0001641172-25-010324.md) | [(0.12)](/filings/0001641172-25-023554.md) | [(0.35)](/filings/0001493152-25-022369.md) | not reported | [(0.10)](/filings/0001493152-26-022787.md) | [(0.07)](/filings/0001493152-26-037397.md) | [(0.22)](/filings/0001493152-25-022369.md) | not reported | [(0.14)](/filings/0001493152-26-022787.md) | [(0.36)](/filings/0001493152-26-037397.md) |
| Basic EPS | $ per share | [(0.25)](/filings/0001493152-24-045164.md) | not reported | [(0.08)](/filings/0001641172-25-010324.md) | [(0.12)](/filings/0001641172-25-023554.md) | [(0.35)](/filings/0001493152-25-022369.md) | not reported | [(0.10)](/filings/0001493152-26-022787.md) | [(0.07)](/filings/0001493152-26-037397.md) | [(0.22)](/filings/0001493152-25-022369.md) | not reported | [(0.14)](/filings/0001493152-26-022787.md) | [(0.36)](/filings/0001493152-26-037397.md) |

- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-11-30) | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [11.4](/filings/0001641172-25-000962.md) | [11.2](/filings/0001641172-25-000962.md) | [10.7](/filings/0001493152-24-018677.md) | [8.2](/filings/0001493152-24-031694.md) | [4.4](/filings/0001493152-24-045164.md) | [3.9](/filings/0001493152-26-011885.md) | [3.0](/filings/0001641172-25-010324.md) | [3.2](/filings/0001641172-25-023554.md) | [3.3](/filings/0001493152-25-022369.md) | [7.4](/filings/0001493152-26-037397.md) | [4.7](/filings/0001493152-26-022787.md) | [7.4](/filings/0001493152-26-037397.md) |
| Current assets | $m | [12.0](/filings/0001641172-25-000962.md) | [11.8](/filings/0001641172-25-000962.md) | [11.2](/filings/0001493152-24-018677.md) | [9.4](/filings/0001493152-24-031694.md) | [5.3](/filings/0001493152-24-045164.md) | [4.1](/filings/0001493152-26-011885.md) | [3.2](/filings/0001641172-25-010324.md) | [3.5](/filings/0001641172-25-023554.md) | [3.8](/filings/0001493152-25-022369.md) | [7.6](/filings/0001493152-26-037397.md) | [6.1](/filings/0001493152-26-022787.md) | [8.2](/filings/0001493152-26-037397.md) |
| Total assets | $m | [13.0](/filings/0001641172-25-000962.md) | [12.8](/filings/0001641172-25-000962.md) | [12.1](/filings/0001493152-24-018677.md) | [10.5](/filings/0001493152-24-031694.md) | [6.4](/filings/0001493152-24-045164.md) | [5.1](/filings/0001493152-26-011885.md) | [4.2](/filings/0001641172-25-010324.md) | [4.4](/filings/0001641172-25-023554.md) | [4.7](/filings/0001493152-25-022369.md) | [8.4](/filings/0001493152-26-037397.md) | [7.1](/filings/0001493152-26-022787.md) | [9.3](/filings/0001493152-26-037397.md) |
| Current liabilities | $m | [0.5](/filings/0001641172-25-000962.md) | [0.5](/filings/0001641172-25-000962.md) | [0.7](/filings/0001493152-24-018677.md) | [0.5](/filings/0001493152-24-031694.md) | [0.7](/filings/0001493152-24-045164.md) | [0.4](/filings/0001493152-26-011885.md) | [0.6](/filings/0001641172-25-010324.md) | [0.5](/filings/0001641172-25-023554.md) | [0.6](/filings/0001493152-25-022369.md) | [0.6](/filings/0001493152-26-037397.md) | [0.6](/filings/0001493152-26-022787.md) | [0.3](/filings/0001493152-26-037397.md) |
| Total liabilities | $m | [0.8](/filings/0001641172-25-000962.md) | [0.8](/filings/0001641172-25-000962.md) | [1.0](/filings/0001493152-24-018677.md) | [0.8](/filings/0001493152-24-031694.md) | [1.0](/filings/0001493152-24-045164.md) | [0.7](/filings/0001493152-26-011885.md) | [0.9](/filings/0001641172-25-010324.md) | [0.8](/filings/0001641172-25-023554.md) | [0.9](/filings/0001493152-25-022369.md) | [0.8](/filings/0001493152-26-037397.md) | [0.9](/filings/0001493152-26-022787.md) | [0.6](/filings/0001493152-26-037397.md) |
| Shareholders' equity | $m | [12.2](/filings/0001641172-25-000962.md) | [12.0](/filings/0001493152-26-011885.md) | [11.1](/filings/0001493152-25-022369.md) | [9.7](/filings/0001493152-25-022369.md) | [5.4](/filings/0001493152-25-022369.md) | [4.4](/filings/0001493152-26-037397.md) | [3.3](/filings/0001493152-26-037397.md) | [3.6](/filings/0001493152-26-037397.md) | [3.9](/filings/0001493152-25-022369.md) | [7.6](/filings/0001493152-26-037397.md) | [6.2](/filings/0001493152-26-037397.md) | [8.7](/filings/0001493152-26-037397.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2023-09-30) | Q4 FY2023 (2023-11-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(2,463) d](/filings/0001493152-24-045164.md) | [(2,404) d](/filings/0001641172-25-000962.md) | [(467)](/filings/0001641172-25-010324.md) | [(2,353) d](/filings/0001641172-25-023554.md) | [(3,821) d](/filings/0001493152-25-022369.md) | [(1,112) d](/filings/0001493152-26-011885.md) | [(921)](/filings/0001493152-26-022787.md) | [(871) d](/filings/0001493152-26-037397.md) | [(2,904) d](/filings/0001493152-25-022369.md) | [(1,146) d](/filings/0001493152-26-011885.md) | [(2,540)](/filings/0001493152-26-022787.md) | [(3,272) d](/filings/0001493152-26-037397.md) |
| Capital expenditure | $k | not reported | not reported | [1.9](/filings/0001641172-25-010324.md) | [170 d](/filings/0001641172-25-023554.md) | [(0.0) d](/filings/0001493152-25-022369.md) | [0.0 d](/filings/0001493152-26-011885.md) | not reported | not reported | not reported | not reported | [237](/filings/0001493152-26-022787.md) | [159 d](/filings/0001493152-26-037397.md) |
| Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [599](/filings/0001493152-26-037397.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | period not labelled (2023-03-31) | period not labelled (2023-06-30) | Q3 FY2023 (2023-08-31) | period not labelled (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [10.1](/filings/0001493152-24-018677.md) | [11.7](/filings/0001493152-24-031694.md) | [12.4](/filings/0001493152-23-036760.md) | [12.4](/filings/0001493152-24-045164.md) | [12.4](/filings/0001641172-25-010324.md) | [12.4](/filings/0001641172-25-023554.md) | [12.4](/filings/0001493152-25-022369.md) | [12.5](/filings/0001493152-26-022787.md) | [12.5](/filings/0001493152-26-037397.md) | [12.7](/filings/0001493152-25-022369.md) | [13.3](/filings/0001493152-26-022787.md) | [13.4](/filings/0001493152-26-037397.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 14,035,736 at 2026-08-12, from the cover of the [10-Q filed 2026-08-12](/filings/0001493152-26-037397.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.